Automate Your Wheel Strategy on CLBT
With Tiblio's Option Bot, you can configure your own wheel strategy including CLBT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CLBT
- Rev/Share 1.6863
- Book/Share 1.4623
- PB 10.668
- Debt/Equity 0.0292
- CurrentRatio 1.8189
- ROIC 0.1458
- MktCap 3735732000.0
- FreeCF/Share 0.5318
- PFCF 28.2625
- PE -19.9643
- Debt/Assets 0.0149
- DivYield 0
- ROE -0.8113
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 3
- P/B Score 1
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Cellebrite to Acquire Corellium
Published: June 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
Combination Delivers Unmatched Innovation in Arm-based Vulnerability and Malware Research, Smart Device DevSecOps and Mobile Pen Testing Combination Delivers Unmatched Innovation in Arm-based Vulnerability and Malware Research, Smart Device DevSecOps and Mobile Pen Testing
Read More
Greenhaven Road Capital Main Fund Q1 2025 Top 5 Holdings
Published: May 19, 2025 by: Seeking Alpha
Sentiment: Positive
Lifecore, Burford, KKR, PAR, and Cellebrite are well-positioned despite trade policy and tariff headwinds, each with unique catalysts for growth. KKR stands out for its asset growth, brand strength, and resilience, benefiting from the migration to private assets and high-net-worth channels. PAR's high-margin software, resilient QSR customer base, and strong growth prospects outweigh tariff risks and support a bullish outlook.
Read More
Cellebrite DI Ltd. (CLBT) Q1 2025 Earnings Call Transcript
Published: May 14, 2025 by: Seeking Alpha
Sentiment: Neutral
Cellebrite DI Ltd. (NASDAQ:CLBT ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Andrew Kramer - IR Tom Hogan - Interim CEO Dana Gerner - CFO Marcus Jewell - CRO Ronnen Armon - Chief Products and Technology Officer Conference Call Participants Tomer Zilberman - Bank of America Jeff Rhee - Craig-Hallum Mike Cikos - Needham Jonathan Ho - William Blair Shaul Eyal - TD Cowen Eric Martinuzzi - Lake Street Operator Welcome to the Cellebrite First Quarter 2025 Financial Results Conference Call.
Read More
Cellebrite DI Ltd. (CLBT) Tops Q1 Earnings Estimates
Published: May 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.09 per share.
Read More
Cellebrite Unveils Spring 2025 Release to Accelerate Global Investigations
Published: May 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
AI and Cloud as Strategic Foundations for the Next Era of its Digital Investigation Platform AI and Cloud as Strategic Foundations for the Next Era of its Digital Investigation Platform
Read More
Cellebrite Files its 2024 Annual Report on Form 20-F
Published: March 18, 2025 by: GlobeNewsWire
Sentiment: Neutral
TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Cellebrite (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced that the Company has filed its Annual Report on Form 20-F for the year ended December 31, 2024, with the U.S. Securities and Exchange Commission (the “SEC”).
Read More
SMGZY or CLBT: Which Is the Better Value Stock Right Now?
Published: February 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Technology Services sector might want to consider either Smiths Group PLC (SMGZY) or Cellebrite DI Ltd. (CLBT). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Is This Stock a Next-Gen Digital Forensics Leader?
Published: February 17, 2025 by: The Motley Fool
Sentiment: Positive
In this video, Anand Chokkavelu, Travis Hoium, and Lou Whiteman discuss Cellebrite (CLBT -5.53%), a key player in digital forensics for law enforcement. They provide ratings and insights on its growth potential, management, and financials, helping you decide if this stock is a worthy investment.
Read More
Cellebrite Announces Fourth-Quarter and Full-Year 2024 Results
Published: February 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
Company delivers “Rule of 50” Performance in 2024 with 25% ARR growth and 25% adjusted EBITDA margin Fourth-quarter 2024 revenue of $109.0 million grew 17% primarily due to 21% growth in subscription revenue ARR grew 25% to $395.9 million Fourth-quarter 2024 adjusted EBITDA of $28.8 million, 26.4% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and twelve months ending December 31, 2024.
Read More
Cellebrite to Report Q4 Earnings: Here's What You Should Know
Published: February 11, 2025 by: Zacks Investment Research
Sentiment: Positive
The surge in subscription filters is likely to have benefited CLBT's top line in the fourth quarter of 2024.
Read More
About Cellebrite DI Ltd. (CLBT)
- IPO Date 2020-11-06
- Website https://www.cellebrite.com
- Industry Software - Infrastructure
- CEO Mr. Thomas E. Hogan
- Employees 1167